Anaplastic Thyroid Carcinoma: Pathogenesis and Emerging Therapies
Top Cited Papers
- 26 April 2010
- journal article
- review article
- Published by Elsevier BV in Clinical Oncology
- Vol. 22 (6), 486-497
- https://doi.org/10.1016/j.clon.2010.03.013
Abstract
No abstract availableKeywords
This publication has 92 references indexed in Scilit:
- Interactions of the Hdm2/p53 and Proteasome Pathways May Enhance the Antitumor Activity of BortezomibClinical Cancer Research, 2009
- Multimodality treatment for anaplastic thyroid carcinoma – Treatment outcome in 75 patientsRadiotherapy and Oncology, 2009
- Mutational Profile of Advanced Primary and Metastatic Radioactive Iodine-Refractory Thyroid Cancers Reveals Distinct Pathogenetic Roles forBRAF, PIK3CA, andAKT1Cancer Research, 2009
- Rising Thyroid Cancer Incidence in the United States by Demographic and Tumor Characteristics, 1980-2005Cancer Epidemiology, Biomarkers & Prevention, 2009
- A Phase II Trial of Fosbretabulin in Advanced Anaplastic Thyroid Carcinoma and Correlation of Baseline Serum-Soluble Intracellular Adhesion Molecule-1 with OutcomeThyroid®, 2009
- Reactivation of Suppressed RhoB is a Critical Step for the Inhibition of Anaplastic Thyroid Cancer GrowthCancer Research, 2009
- Potent Inhibition of Thyroid Cancer Cells by the MEK Inhibitor PD0325901 and Its Potentiation by Suppression of the PI3K and NF-κB PathwaysThyroid®, 2008
- Poorly differentiated and anaplastic thyroid carcinomas: chromosomal and oligo-array profile of five new cell linesBritish Journal of Cancer, 2007
- MicroRNA Signatures in Human CancersNature Reviews Cancer, 2006
- Increasing Incidence of Thyroid Cancer in the United States, 1973-2002JAMA, 2006